Evidence map›Paper›PMID 37921990›Full record

SynthesisJournal of endocrinological investigation2024

Refracture following vertebral fragility fracture when bone fragility is not recognized: summarizing findings from comparator arms of randomized clinical trials.

G Porcu, A Biffi, R Ronco, G Adami, R Alvaro, R Bogini, A P Caputi, B Frediani, D Gatti, S Gonnelli and 14 more

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Journal of endocrinological investigation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Sentinel fracture: the necessity of improved post-fracture care.Wiener medizinische Wochenschrift (1946) · 2025
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 10 institutions in 1 country.

G PorcuDepartment of Statistics and Quantitative Methods, National Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy. gloria.porcu@unimib.it.ORCID http://orcid.org/0000-0002-9871-4129
A BiffiDepartment of Statistics and Quantitative Methods, National Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy.
R RoncoDepartment of Statistics and Quantitative Methods, National Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy.
G AdamiRheumatology Unit, University of Verona, Verona, Italy.
R AlvaroDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
R BoginiLocal Health Unit (USL) Umbria, Perugia, Italy.
A P CaputiDepartment of Pharmacology, School of Medicine, University of Messina, Messina, Italy.
B FredianiDepartment of Medicine, Surgery and Neurosciences, Rheumatology Unit, University of Siena, Azienda Ospedaliero-Universitaria Senese, Siena, Italy.
D GattiRheumatology Unit, University of Verona, Verona, Italy.
S GonnelliDepartment of Medicine, Surgery, and Neuroscience, Policlinico Le Scotte, University of Siena, Siena, Italy.
G IolasconDepartment of Medical and Surgical Specialties and Dentistry, University of Campania "Luigi Vanvitelli", Naples, Italy.
A LenziDepartment of Experimental Medicine, Sapienza University of Rome, Viale del Policlinico, Rome, Italy.
S LeoneAMICI Onlus, Associazione nazionale per le Malattie Infiammatorie Croniche dell'Intestino, Milan, Italy.
R MichieliItalian Society of General Medicine and Primary Care (SIMG), Florence, Italy.
S MigliaccioDepartment of Movement, Human and Health Sciences, Foro Italico University, Rome, Italy.
T NicolettiCnAMC, Coordinamento nazionale delle Associazioni dei Malati Cronici e rari di Cittadinanzattiva, Rome, Italy.
M PaolettaDepartment of Medical and Surgical Specialties and Dentistry, University of Campania "Luigi Vanvitelli", Naples, Italy.
A PenniniRheumatology Unit, University of Verona, Verona, Italy.
E PiccirilliDepartment of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.
M RossiniRheumatology Unit, University of Verona, Verona, Italy.
U TarantinoDepartment of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.
L CianferottiItalian Foundation for Research on Bone Diseases (FIRMO), Florence, Italy.
M L BrandiItalian Foundation for Research on Bone Diseases (FIRMO), Florence, Italy.
G CorraoDepartment of Statistics and Quantitative Methods, National Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy.
University of Verona · ITUniversity of Milano-Bicocca · ITUniversity of Rome Tor Vergata · ITUniversity of Campania "Luigi Vanvitelli" · ITUniversity of Siena · ITForo Italico University of Rome · ITPoliclinico Umberto I · ITSocietà Italiana di Medicina Generale · ITUniversity of Messina · ITUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSince vertebral fragility fractures (VFFs) might increase the risk of subsequent fractures, we evaluated the incidence rate and the refracture risk of subsequent vertebral and non-vertebral fragility fractures (nVFFs) in untreated patients with a previous VFF.

methodsWe systematically searched PubMed, Embase, and Cochrane Library up to February 2022 for randomized clinical trials (RCTs) that analyzed the occurrence of subsequent fractures in untreated patients with prior VFFs. Two authors independently extracted data and appraised the risk of bias in the selected studies. Primary outcomes were subsequent VFFs, while secondary outcomes were further nVFFs. The outcome of refracture within ≥ 2 years after the index fracture was measured as (i) rate, expressed per 100 person-years (PYs), and (ii) risk, expressed in percentage.

resultsForty RCTs met our inclusion criteria, ranging from medium to high quality. Among untreated patients with prior VFFs, the rate of subsequent VFFs and nVFFs was 12 [95% confidence interval (CI) 9-16] and 6 (95% CI 5-8%) per 100 PYs, respectively. The higher the number of previous VFFs, the higher the incidence. Moreover, the risk of VFFs and nVFFs increased within 2 (16.6% and 8%) and 4 years (35.1% and 17.4%) based on the index VFF.

conclusionThe highest risk of subsequent VFFs or nVFFs was already detected within 2 years following the initial VFF. Thus, prompt interventions should be designed to improve the detection and treatment of VFFs, aiming to reduce the risk of future FFs and properly implement secondary preventive measures.

Indexed as

Fractures, BoneOsteoporotic FracturesSpinal FracturesHumansRandomized Controlled Trials as TopicSpineRefractureSubsequent fracturesSystematic reviewVertebral fragility fracture

Identifiers

PMID37921990
PMCPMC10965723
OpenAlexW4388297894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.